# AVANDIA With Glyburide In African American And Hispanic Patients With Type 2 Diabetes Not Controlled by Glyburide Alone

> **NCT00333723** · PHASE4 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 245 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Rosiglitazone

## Key facts

- **NCT ID:** NCT00333723
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-07-28
- **Primary completion:** 2003-01-06
- **Final completion:** 2003-01-06
- **Target enrollment:** 245 (ACTUAL)
- **Last updated:** 2017-10-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00333723

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00333723, "AVANDIA With Glyburide In African American And Hispanic Patients With Type 2 Diabetes Not Controlled by Glyburide Alone". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00333723. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*